Have a feature idea you'd love to see implemented?
Let us know!
ALZN Alzamend Neuro Inc
Price (delayed)
$1.2
Market cap
$6.52M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$6.65
Enterprise value
$2.43M
Highlights
ALZN's EPS has soared by 71% year-on-year and by 38% since the previous quarter
ALZN's net income has soared by 61% year-on-year and by 21% since the previous quarter
Key stats
What are the main financial stats of ALZN
Market
Valuations
Earnings
Shares outstanding
5.43M
Market cap
$6.52M
Enterprise value
$2.43M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.24
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Net income
-$5.85M
EBIT
-$5.83M
EBITDA
-$5.78M
Free cash flow
-$8M
Per share
Balance sheet
Liquidity
EPS
-$6.65
EPS diluted
-$6.65
Free cash flow per share
-$2.27
Book value per share
$0.96
Revenue per share
$0
TBVPS
$1.42
Total assets
$5.01M
Total liabilities
$1.25M
Debt
$0
Equity
$3.75M
Working capital
$3.51M
Debt to equity
0
Current ratio
3.8
Quick ratio
3.26
Net debt/EBITDA
0.71
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-291.8%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-155.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ALZN stock price
How has the Alzamend Neuro stock price performed over time
Intraday
0%
1 week
4.35%
1 month
-7.69%
1 year
-86.52%
YTD
-86.52%
QTD
-28.99%
Financial performance
How have Alzamend Neuro's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$5.83M
Net income
-$5.85M
Gross margin
N/A
Net margin
N/A
ALZN's operating income has surged by 62% year-on-year and by 21% since the previous quarter
ALZN's net income has soared by 61% year-on-year and by 21% since the previous quarter
Growth
What is Alzamend Neuro's growth rate over time
Valuation
What is Alzamend Neuro stock price valuation
P/E
N/A
P/B
1.24
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ALZN's EPS has soared by 71% year-on-year and by 38% since the previous quarter
Efficiency
How efficient is Alzamend Neuro business performance
ALZN's ROA has soared by 60% from the previous quarter and by 13% YoY
Dividends
What is ALZN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ALZN.
Financial health
How did Alzamend Neuro financials performed over time
Alzamend Neuro's total assets has soared by 200% from the previous quarter
The company's total liabilities has shrunk by 66% YoY and by 56% QoQ
ALZN's debt is 100% smaller than its equity
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.